The collaboration among UAB, University of Wisconsin and Duke University will use bioengineered stem cells and bioengineered tissue to treat heart failure after heart attacks.
The zebrafish is making its mark in the field of biomedical research, becoming one of the fastest-growing models of human disease.
The new Kirklin Institute for Research in Surgical Outcomes positions UAB as a world leader in improving patient outcomes.
Springing forward with daylight saving time may increase your risk of having a heart attack if you have a history of heart disease.
Published in Focus on Patient Care
Middle aged and older workers at higher risk for cardiovascular health in some jobs.
UAB’s Virginia Howard has been honored for her work to find novel and powerful approaches to reduce the burden of stroke and heart disease.
Published in Faculty Excellence
An Arizona drug company will patent the small peptide drug.
Research revealing new evidence about the role of the spleen following heart attack will be honored during the AHA scientific meeting Nov. 15-19.
Published in Faculty Excellence
Back to Top